Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers

We are analyzing https://www.nature.com/articles/s41419-022-05117-9.

Title:
ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth | Cell Death & Disease
Description:
A significant proportion of breast cancers are driven by ErbB2/Her2 oncoprotein that they overexpress. These malignancies are typically treated with various ErbB2-targeted drugs, but many such cancers develop resistance to these agents and become incurable. Conceivably, treatment of ErbB2-positive cancers could be facilitated by use of agents blocking oncogenic signaling mechanisms downstream of ErbB2. However, current understanding of these mechanisms is limited. The ability of solid tumor cells to resist anoikis, cell death triggered by cell detachment from the extracellular matrix (ECM), is thought to be critical for 3D tumor growth. In an effort to understand the mechanisms of ErbB2-driven breast cancer cell anoikis resistance we found that detachment of non-malignant breast epithelial cells from the ECM upregulates a cell death-promoting tumor suppressor adapter protein BLNK and that ErbB2 blocks this upregulation by reducing tumor cell levels of transcription factor IRF6. We further observed that trastuzumab, a therapeutic anti-ErbB2 antibody, upregulates BLNK in human trastuzumab-sensitive but not trastuzumab-resistant ErbB2-positive breast cancer cells. Moreover, we established that BLNK promotes anoikis by activating p38 MAP kinase and that ErbB2-dependent BLNK downregulation blocks breast cancer cell anoikis. In search for pharmacological approaches allowing to upregulate BLNK in tumor cells we found that clinically approved proteasome inhibitor bortezomib upregulates IRF6 and BLNK in human breast cancer cells and inhibits their 3D growth in a BLNK-dependent manner. In addition, we found that BLNK upregulation in human ErbB2-positive breast cancer cells blocks their ability to form tumors in mice. Furthermore, we used publicly available data on mRNA levels in multiple breast cancers to demonstrate that increased BLNK mRNA levels correlate with increased relapse-free survival in a cohort of approximately 400 patients with ErbB2-positive breast cancer. In summary, we discovered a novel mechanism of ErbB2-driven 3D breast tumor growth mediated by ErbB2-dependent BLNK downregulation.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$63,100 per month
Our calculations suggest that Nature.com earns between $42,042 and $115,616 monthly online from display advertisements.

Keywords {🔍}

cells, blnk, breast, cancer, cell, article, fig, detached, google, scholar, irf, anoikis, cas, erbb, ecm, expression, tumor, downregulation, control, found, epithelial, cultured, data, protein, erbbpositive, growth, mcfa, mcferbb, assayed, death, levels, medium, pmapk, nature, presence, blocks, factor, survival, bortezomib, usa, upregulation, increased, vector, annexin, doxycycline, western, published, treatment, mechanisms, observed,

Topics {✒️}

nature portfolio privacy policy pretrox-tetone™-puro expression vector bamhi-digested pretrox-tetone™-puro mcf-erbb2 cells mcf-erbb2-blnk nature annexin v-negative/7aad-positive cells pretrox-tetone™-puro- blnk vectors pretrox-tetone™-hygro-blnk vectors advertising erbb2/her2-positive breast carcinoma mitogen-activated protein kinase pbabe-hygro-irf6 expression vector sunnybrook research institute kaplan–meier analysis-based estimation annexin v-positive/7aad-negative annexin v-positive/7aad-positive irf6-overproducing mcf-erbb2 cells generate blnk-deficient cells social media control mcf-erbb2-vector cells erbb2-positive breast cancer pbabe-hygro expression vector reprints central proline-rich region erbb2-dependent erk activation pro-apoptotic protein perp erbb2/her2-dependent downregulation supplementary table 1 erbb2-dependent blnk downregulation breast development pbabe-irf6 expression vector medical research erbb2-induced blnk downregulation increased disease-free survival therapeutic anti-erbb2 antibody cell cycle-dependent manner pretrox-tetone™-puro c-terminal sh2 domain parental mcf-erbb2 cells health research pro-apoptotic protein bim pro-apoptotic proteins bax pretrox-tetone™-hygro erbb2-induced 3d growth original author nu/nu nude mice chromatin immunoprecipitation-sequencing analysis mcf-erbb2-blnk cells cells bt474t-blnk carrying

Schema {🗺️}

WebPage:
      mainEntity:
         headline:ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth
         description:A significant proportion of breast cancers are driven by ErbB2/Her2 oncoprotein that they overexpress. These malignancies are typically treated with various ErbB2-targeted drugs, but many such cancers develop resistance to these agents and become incurable. Conceivably, treatment of ErbB2-positive cancers could be facilitated by use of agents blocking oncogenic signaling mechanisms downstream of ErbB2. However, current understanding of these mechanisms is limited. The ability of solid tumor cells to resist anoikis, cell death triggered by cell detachment from the extracellular matrix (ECM), is thought to be critical for 3D tumor growth. In an effort to understand the mechanisms of ErbB2-driven breast cancer cell anoikis resistance we found that detachment of non-malignant breast epithelial cells from the ECM upregulates a cell death-promoting tumor suppressor adapter protein BLNK and that ErbB2 blocks this upregulation by reducing tumor cell levels of transcription factor IRF6. We further observed that trastuzumab, a therapeutic anti-ErbB2 antibody, upregulates BLNK in human trastuzumab-sensitive but not trastuzumab-resistant ErbB2-positive breast cancer cells. Moreover, we established that BLNK promotes anoikis by activating p38 MAP kinase and that ErbB2-dependent BLNK downregulation blocks breast cancer cell anoikis. In search for pharmacological approaches allowing to upregulate BLNK in tumor cells we found that clinically approved proteasome inhibitor bortezomib upregulates IRF6 and BLNK in human breast cancer cells and inhibits their 3D growth in a BLNK-dependent manner. In addition, we found that BLNK upregulation in human ErbB2-positive breast cancer cells blocks their ability to form tumors in mice. Furthermore, we used publicly available data on mRNA levels in multiple breast cancers to demonstrate that increased BLNK mRNA levels correlate with increased relapse-free survival in a cohort of approximately 400 patients with ErbB2-positive breast cancer. In summary, we discovered a novel mechanism of ErbB2-driven 3D breast tumor growth mediated by ErbB2-dependent BLNK downregulation.
         datePublished:2022-08-06T00:00:00Z
         dateModified:2022-08-06T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41419-022-05117-9
         keywords:
            Cancer
            Cell biology
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Immunology
            Cell Culture
            Antibodies
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig9_HTML.png
         isPartOf:
            name:Cell Death & Disease
            issn:
               2041-4889
            volumeNumber:13
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Xiaoyang Liu
               affiliation:
                     name:Dalhousie University
                     address:
                        name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sandhya Chipurupalli
               url:http://orcid.org/0000-0002-2065-3880
               affiliation:
                     name:Dalhousie University
                     address:
                        name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peijia Jiang
               affiliation:
                     name:Dalhousie University
                     address:
                        name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mahtab Tavasoli
               affiliation:
                     name:Dalhousie University
                     address:
                        name:Department of Pharmacology, Department of Pediatrics, Dalhousie University, Halifax, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Byong Hoon Yoo
               affiliation:
                     name:Dalhousie University
                     address:
                        name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael McPhee
               affiliation:
                     name:Dalhousie University
                     address:
                        name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sina Mazinani
               affiliation:
                     name:Dalhousie University
                     address:
                        name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giulio Francia
               affiliation:
                     name:University of Texas at El Paso (UTEP)
                     address:
                        name:Border Biomedical Research Center, University of Texas at El Paso (UTEP), El Paso, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Robert S. Kerbel
               url:http://orcid.org/0000-0002-6015-2570
               affiliation:
                     name:Sunnybrook Research Institute
                     address:
                        name:Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Canada
                        type:PostalAddress
                     type:Organization
                     name:University of Toronto Department of Medical Biophysics
                     address:
                        name:University of Toronto Department of Medical Biophysics, Toronto, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kirill V. Rosen
               url:http://orcid.org/0000-0002-4317-9907
               affiliation:
                     name:Dalhousie University
                     address:
                        name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth
      description:A significant proportion of breast cancers are driven by ErbB2/Her2 oncoprotein that they overexpress. These malignancies are typically treated with various ErbB2-targeted drugs, but many such cancers develop resistance to these agents and become incurable. Conceivably, treatment of ErbB2-positive cancers could be facilitated by use of agents blocking oncogenic signaling mechanisms downstream of ErbB2. However, current understanding of these mechanisms is limited. The ability of solid tumor cells to resist anoikis, cell death triggered by cell detachment from the extracellular matrix (ECM), is thought to be critical for 3D tumor growth. In an effort to understand the mechanisms of ErbB2-driven breast cancer cell anoikis resistance we found that detachment of non-malignant breast epithelial cells from the ECM upregulates a cell death-promoting tumor suppressor adapter protein BLNK and that ErbB2 blocks this upregulation by reducing tumor cell levels of transcription factor IRF6. We further observed that trastuzumab, a therapeutic anti-ErbB2 antibody, upregulates BLNK in human trastuzumab-sensitive but not trastuzumab-resistant ErbB2-positive breast cancer cells. Moreover, we established that BLNK promotes anoikis by activating p38 MAP kinase and that ErbB2-dependent BLNK downregulation blocks breast cancer cell anoikis. In search for pharmacological approaches allowing to upregulate BLNK in tumor cells we found that clinically approved proteasome inhibitor bortezomib upregulates IRF6 and BLNK in human breast cancer cells and inhibits their 3D growth in a BLNK-dependent manner. In addition, we found that BLNK upregulation in human ErbB2-positive breast cancer cells blocks their ability to form tumors in mice. Furthermore, we used publicly available data on mRNA levels in multiple breast cancers to demonstrate that increased BLNK mRNA levels correlate with increased relapse-free survival in a cohort of approximately 400 patients with ErbB2-positive breast cancer. In summary, we discovered a novel mechanism of ErbB2-driven 3D breast tumor growth mediated by ErbB2-dependent BLNK downregulation.
      datePublished:2022-08-06T00:00:00Z
      dateModified:2022-08-06T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41419-022-05117-9
      keywords:
         Cancer
         Cell biology
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Immunology
         Cell Culture
         Antibodies
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-022-05117-9/MediaObjects/41419_2022_5117_Fig9_HTML.png
      isPartOf:
         name:Cell Death & Disease
         issn:
            2041-4889
         volumeNumber:13
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Xiaoyang Liu
            affiliation:
                  name:Dalhousie University
                  address:
                     name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sandhya Chipurupalli
            url:http://orcid.org/0000-0002-2065-3880
            affiliation:
                  name:Dalhousie University
                  address:
                     name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peijia Jiang
            affiliation:
                  name:Dalhousie University
                  address:
                     name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mahtab Tavasoli
            affiliation:
                  name:Dalhousie University
                  address:
                     name:Department of Pharmacology, Department of Pediatrics, Dalhousie University, Halifax, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Byong Hoon Yoo
            affiliation:
                  name:Dalhousie University
                  address:
                     name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael McPhee
            affiliation:
                  name:Dalhousie University
                  address:
                     name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sina Mazinani
            affiliation:
                  name:Dalhousie University
                  address:
                     name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giulio Francia
            affiliation:
                  name:University of Texas at El Paso (UTEP)
                  address:
                     name:Border Biomedical Research Center, University of Texas at El Paso (UTEP), El Paso, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Robert S. Kerbel
            url:http://orcid.org/0000-0002-6015-2570
            affiliation:
                  name:Sunnybrook Research Institute
                  address:
                     name:Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Canada
                     type:PostalAddress
                  type:Organization
                  name:University of Toronto Department of Medical Biophysics
                  address:
                     name:University of Toronto Department of Medical Biophysics, Toronto, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kirill V. Rosen
            url:http://orcid.org/0000-0002-4317-9907
            affiliation:
                  name:Dalhousie University
                  address:
                     name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Disease
      issn:
         2041-4889
      volumeNumber:13
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Dalhousie University
      address:
         name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
         type:PostalAddress
      name:Dalhousie University
      address:
         name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
         type:PostalAddress
      name:Dalhousie University
      address:
         name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
         type:PostalAddress
      name:Dalhousie University
      address:
         name:Department of Pharmacology, Department of Pediatrics, Dalhousie University, Halifax, Canada
         type:PostalAddress
      name:Dalhousie University
      address:
         name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
         type:PostalAddress
      name:Dalhousie University
      address:
         name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
         type:PostalAddress
      name:Dalhousie University
      address:
         name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
         type:PostalAddress
      name:University of Texas at El Paso (UTEP)
      address:
         name:Border Biomedical Research Center, University of Texas at El Paso (UTEP), El Paso, USA
         type:PostalAddress
      name:Sunnybrook Research Institute
      address:
         name:Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Canada
         type:PostalAddress
      name:University of Toronto Department of Medical Biophysics
      address:
         name:University of Toronto Department of Medical Biophysics, Toronto, Canada
         type:PostalAddress
      name:Dalhousie University
      address:
         name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Xiaoyang Liu
      affiliation:
            name:Dalhousie University
            address:
               name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
               type:PostalAddress
            type:Organization
      name:Sandhya Chipurupalli
      url:http://orcid.org/0000-0002-2065-3880
      affiliation:
            name:Dalhousie University
            address:
               name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
               type:PostalAddress
            type:Organization
      name:Peijia Jiang
      affiliation:
            name:Dalhousie University
            address:
               name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
               type:PostalAddress
            type:Organization
      name:Mahtab Tavasoli
      affiliation:
            name:Dalhousie University
            address:
               name:Department of Pharmacology, Department of Pediatrics, Dalhousie University, Halifax, Canada
               type:PostalAddress
            type:Organization
      name:Byong Hoon Yoo
      affiliation:
            name:Dalhousie University
            address:
               name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
               type:PostalAddress
            type:Organization
      name:Michael McPhee
      affiliation:
            name:Dalhousie University
            address:
               name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
               type:PostalAddress
            type:Organization
      name:Sina Mazinani
      affiliation:
            name:Dalhousie University
            address:
               name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
               type:PostalAddress
            type:Organization
      name:Giulio Francia
      affiliation:
            name:University of Texas at El Paso (UTEP)
            address:
               name:Border Biomedical Research Center, University of Texas at El Paso (UTEP), El Paso, USA
               type:PostalAddress
            type:Organization
      name:Robert S. Kerbel
      url:http://orcid.org/0000-0002-6015-2570
      affiliation:
            name:Sunnybrook Research Institute
            address:
               name:Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Canada
               type:PostalAddress
            type:Organization
            name:University of Toronto Department of Medical Biophysics
            address:
               name:University of Toronto Department of Medical Biophysics, Toronto, Canada
               type:PostalAddress
            type:Organization
      name:Kirill V. Rosen
      url:http://orcid.org/0000-0002-4317-9907
      affiliation:
            name:Dalhousie University
            address:
               name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
      name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
      name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
      name:Department of Pharmacology, Department of Pediatrics, Dalhousie University, Halifax, Canada
      name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
      name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
      name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada
      name:Border Biomedical Research Center, University of Texas at El Paso (UTEP), El Paso, USA
      name:Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Canada
      name:University of Toronto Department of Medical Biophysics, Toronto, Canada
      name:Departments of Pediatrics & Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada

Social Networks {👍}(1)

External Links {🔗}(121)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk
4.68s.